• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Cerulean Pharma Inc

+ Add to Watchlist


4.4900 USD 0.1800 3.85%

As of 17:20:00 ET on 08/22/2014.

Snapshot for Cerulean Pharma Inc (CERU)

Open: 4.6700 Day's Range: 4.4000 - 4.8900 Volume: 42,326
Previous Close: 4.6700 52wk Range: 3.3500 - 8.0600 1-Yr Rtn: -

Stock Chart for CERU

No chart data available.
  • CERU:US 4.5300
  • 1D
  • 1M
  • 1Y
Interactive CERU Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CERU

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.9050
Est. PEG Ratio -
Market Cap (M USD) 88.75
Shares Outstanding (M) 20.12
30 Day Average Volume 59,205
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CERU

No data available

Company Profile & Key Executives for CERU

Cerulean Pharma, Inc. designs and develops pharmaceutical products. The Company manufactures therapeutics in the areas of oncology, cardiovascular, autoimmune, and inflammatory diseases as well as tumor cells. Cerulean Pharma operates in the United States.

Oliver S FetzerPresident/CEOEdward GarmeySenior VP/Chief Medical Ofcr
Christopher Damien T Guiffre "Chris"Senior VP/Chief Business OfcrJean SilveriSenior VP/General Counsel
More Company Profile & Key Executives for CERU

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil